![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NXPH4 |
Gene summary for NXPH4 |
![]() |
Gene information | Species | Human | Gene symbol | NXPH4 | Gene ID | 11247 |
Gene name | neurexophilin 4 | |
Gene Alias | NPH4 | |
Cytomap | 12q13.3 | |
Gene Type | protein-coding | GO ID | GO:0007154 | UniProtAcc | O95158 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
11247 | NXPH4 | LZE20T | Human | Esophagus | ESCC | 3.61e-13 | 3.61e-01 | 0.0662 |
11247 | NXPH4 | LZE22T | Human | Esophagus | ESCC | 1.48e-05 | 3.53e-01 | 0.068 |
11247 | NXPH4 | LZE24T | Human | Esophagus | ESCC | 4.15e-02 | 8.96e-02 | 0.0596 |
11247 | NXPH4 | P2T-E | Human | Esophagus | ESCC | 6.89e-44 | 8.18e-01 | 0.1177 |
11247 | NXPH4 | P4T-E | Human | Esophagus | ESCC | 2.84e-55 | 1.25e+00 | 0.1323 |
11247 | NXPH4 | P5T-E | Human | Esophagus | ESCC | 5.35e-16 | 3.91e-01 | 0.1327 |
11247 | NXPH4 | P8T-E | Human | Esophagus | ESCC | 3.75e-03 | 8.98e-02 | 0.0889 |
11247 | NXPH4 | P10T-E | Human | Esophagus | ESCC | 7.31e-14 | 2.59e-01 | 0.116 |
11247 | NXPH4 | P11T-E | Human | Esophagus | ESCC | 2.06e-07 | 3.66e-01 | 0.1426 |
11247 | NXPH4 | P12T-E | Human | Esophagus | ESCC | 9.02e-11 | 2.50e-01 | 0.1122 |
11247 | NXPH4 | P15T-E | Human | Esophagus | ESCC | 3.15e-42 | 9.25e-01 | 0.1149 |
11247 | NXPH4 | P16T-E | Human | Esophagus | ESCC | 7.98e-13 | 2.44e-01 | 0.1153 |
11247 | NXPH4 | P17T-E | Human | Esophagus | ESCC | 3.31e-19 | 8.45e-01 | 0.1278 |
11247 | NXPH4 | P19T-E | Human | Esophagus | ESCC | 6.53e-04 | 4.25e-01 | 0.1662 |
11247 | NXPH4 | P20T-E | Human | Esophagus | ESCC | 2.72e-14 | 3.59e-01 | 0.1124 |
11247 | NXPH4 | P21T-E | Human | Esophagus | ESCC | 1.96e-05 | 1.07e-01 | 0.1617 |
11247 | NXPH4 | P22T-E | Human | Esophagus | ESCC | 3.52e-19 | 3.37e-01 | 0.1236 |
11247 | NXPH4 | P23T-E | Human | Esophagus | ESCC | 7.44e-14 | 4.70e-01 | 0.108 |
11247 | NXPH4 | P24T-E | Human | Esophagus | ESCC | 4.05e-32 | 7.72e-01 | 0.1287 |
11247 | NXPH4 | P26T-E | Human | Esophagus | ESCC | 1.74e-96 | 2.06e+00 | 0.1276 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Cervix | N_HPV | ![]() |
Endometrium | AEH | ![]() |
Endometrium | EEC | ![]() |
Prostate | BPH | ![]() |
Prostate | Tumor | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NXPH4 | SNV | Missense_Mutation | novel | c.922N>A | p.Gly308Arg | p.G308R | O95158 | protein_coding | deleterious_low_confidence(0) | probably_damaging(1) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
NXPH4 | SNV | Missense_Mutation | novel | c.55N>G | p.Lys19Glu | p.K19E | O95158 | protein_coding | tolerated_low_confidence(0.28) | benign(0) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
NXPH4 | SNV | Missense_Mutation | novel | c.415N>C | p.Tyr139His | p.Y139H | O95158 | protein_coding | tolerated(0.07) | benign(0.376) | TCGA-AJ-A3BH-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
NXPH4 | SNV | Missense_Mutation | novel | c.884N>A | p.Cys295Tyr | p.C295Y | O95158 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
NXPH4 | SNV | Missense_Mutation | novel | c.439C>A | p.Leu147Met | p.L147M | O95158 | protein_coding | tolerated(0.07) | probably_damaging(0.985) | TCGA-AX-A2HA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
NXPH4 | SNV | Missense_Mutation | novel | c.4N>T | p.Arg2Trp | p.R2W | O95158 | protein_coding | deleterious_low_confidence(0) | possibly_damaging(0.876) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
NXPH4 | SNV | Missense_Mutation | c.688G>A | p.Ala230Thr | p.A230T | O95158 | protein_coding | tolerated(0.59) | benign(0.005) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
NXPH4 | SNV | Missense_Mutation | c.724C>A | p.Arg242Ser | p.R242S | O95158 | protein_coding | deleterious(0) | probably_damaging(0.941) | TCGA-D1-A17S-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
NXPH4 | SNV | Missense_Mutation | novel | c.536N>T | p.Thr179Met | p.T179M | O95158 | protein_coding | deleterious(0) | probably_damaging(0.912) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
NXPH4 | SNV | Missense_Mutation | c.821N>C | p.Phe274Ser | p.F274S | O95158 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-DD-A4NV-01 | Liver | liver hepatocellular carcinoma | Male | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |